Rapport Therapeutics, Inc. (RAPP) compared with its closest peers (OVID, TSHA, SION, TNXP, PGEN). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Ovid Therapeutics, Taysha Gene Therapies, Sionna Therapeutics, Tonix Pharmaceuticals, Precigen, Crinetics Pharmaceuticals, Contineum Therapeutics, Veru, Crescent Biopharma and Opus Genetics share Rapport Therapeutics's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Ovid Therapeutics Inc. (OVID) | $523.40M | — |
| Taysha Gene Therapies, Inc. (TSHA) | $1.44B | — |
| Sionna Therapeutics, Inc. (SION) | $354.01M | — |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | $188.74M | — |
| Precigen, Inc. (PGEN) | $2.45B | — |
| Crinetics Pharmaceuticals, Inc. (CRNX) | $9.01B | — |
| Contineum Therapeutics, Inc. (CTNM) | $554.52M | — |
| Veru Inc. (VERU) | $39.40M | — |
| Crescent Biopharma, Inc. (CBIO) | $717.99M | — |
| Opus Genetics, Inc. (IRD) | $500.84M | — |
| Sector P/E (Healthcare) | 19.4 |
| Industry P/E (Pharmaceutical Products) | 15.1 |
RAPP overview · RAPP earnings · RAPP financials · RAPP KPIs · RAPP documents · RAPP ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.